The coronavirus vaccine produced by Oxford University and AstraZeneca will be available on a non-profit basis “in perpetuity” to low- and middle-income countries in the developing world. The details of arrangements to supply poorer countries came as AstraZeneca revealed the interim results of a phase 3 trial of the […]

The post Oxford AstraZeneca vaccine to be sold to developing countries at cost price appeared first on The New York Beacon.